If you know someone who suffers from kidney cancer, renal failure, or liver cancer, then you may already be familiar with dialysis treatments. Patients whose organs lack the ability to cleanse the blood naturally are often prescribed dialysis treatment by their doctors. Every year, over 350,000 patients receive dialysis treatment, which is a form of medical treatment that cleanses the blood of excess fluid and toxins through the use of a machine. The machine, in effect, would act as an artificial kidney.
One of the largest distributors of dialysis treatments and drugs, Fresenius Medical Care, administered its drugs to kidney cancer patients on dialysis. Two commonly used drugs, GranuFlo® and NaturaLyte® are being treated to dialysis patients across the globe, and even at medical centers not owned by Fresenius.
The shocking news is that GranuFlo® and NaturaLyte® were recently found to be defected. The drugs caused severe complications that lead many to suffer heart attacks and even death. Thousands of patients received these defective drugs, and suffered complications as a result. In the cases that patients are fortunate enough to survive from the complications, they will find daily capabilities a difficulty.
Fresenius published an internal memo documenting the research results from its own study. The research results listed several complications and injuries that were most common among patients who took defective products GranuFlo® and NaturaLyte®.
Fresenius's internal memo warned doctors and nurses about monitoring their patients' blood sugar level and blood pressure as well as a number of other chemical and toxin levels. Fresenius warned its own doctors about the drugs but did not tell them to stop using them. GranuFlo® and NaturaLyte® were kept on the market and administered to dialysis patients, and as a result, thousands of patients put themselves at risk without knowing about the dangers.
Despite the findings that GranuFlo® and NaturaLyte® are dangerous, the defective products continued to be sold on the market. Fresenius did nothing to warn the public. Instead, patients were given the drugs without knowing the risks they were taking. Though the internal memo was sent out among Fresenius's company-owned clinics, physicians, and nurses, the public stayed oblivious to the dangers. The announcements were kept a secret within the company, and thousands of patients receiving drugs at other clinics, along with their doctors and nurses, were not aware of the risks associated with GranuFlo® and NaturaLyte®.
As a result, doctors unknowingly distributed harmful drugs to dialysis patients, kidney cancer patients, and victims suffering from renal failure.
Because the company knew about the risks and did nothing to warn patients or stop the drugs from being administered, Fresenius Medical Care is now the target of a lawsuit. Since the news that GranuFlo® and NaturaLyte® are dangerous and cause serious harm to patients, many are stepping forth and speaking up about their problems.
Our medical injury and defective product attorneys aim to hold Fresenius responsible for its negligence. Fresenius had a legal responsibility toward its patients, and we want to make sure the company holds up to that responsibility.
If you have been injured after taking GranuFlo® and NaturaLyte®, then you are not alone. You may be eligible for compensation, but there is no way to know unless you speak to one of our kidney cancer and dialysis injury attorneys. Our toll-free number is available for you to call any time of any day, or you may choose to fill out the free case evaluation form. We are here to listen and do what we can to help you determine your next step
Tell us about your injury or accident for a free confidential review by an experienced attorney.